Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 100, Issue 2
Long-term outcomes of intravitreal ranibizumab for neovascular age-related macular degeneration in a well defined region of the UK
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical science
Long-term outcomes of intravitreal ranibizumab for neovascular age-related macular degeneration in a well defined region of the UK
Online download statistics by month:
Online download statistics by month: June 2015 to September 2024
Abstract
Full
Pdf
Jun 2015
134
6
9
Jul 2015
203
32
45
Aug 2015
31
18
21
Sep 2015
48
5
13
Oct 2015
39
4
8
Nov 2015
28
4
4
Dec 2015
22
4
5
Jan 2016
420
20
37
Feb 2016
473
22
50
Mar 2016
174
4
17
Apr 2016
100
7
18
May 2016
81
3
7
Jun 2016
77
4
9
Jul 2016
46
10
11
Aug 2016
64
5
14
Sep 2016
39
3
2
Oct 2016
42
4
9
Nov 2016
41
5
12
Dec 2016
36
5
3
Jan 2017
50
7
7
Feb 2017
23
7
9
Mar 2017
23
9
11
Apr 2017
21
17
6
May 2017
26
6
5
Jun 2017
16
6
6
Jul 2017
56
9
4
Aug 2017
69
8
6
Sep 2017
171
5
4
Oct 2017
320
4
4
Nov 2017
143
16
1
Dec 2017
110
40
5
Jan 2018
79
32
3
Feb 2018
85
19
1
Mar 2018
75
21
3
Apr 2018
57
23
7
May 2018
104
15
2
Jun 2018
48
21
1
Jul 2018
75
29
1
Aug 2018
70
27
2
Sep 2018
74
30
1
Oct 2018
53
25
9
Nov 2018
45
20
3
Dec 2018
40
22
4
Jan 2019
64
22
5
Feb 2019
70
23
5
Mar 2019
36
3
1
Apr 2019
15
3
1
May 2019
32
10
3
Jun 2019
30
19
2
Jul 2019
46
16
1
Aug 2019
40
17
7
Sep 2019
44
20
2
Oct 2019
47
20
3
Nov 2019
36
14
1
Dec 2019
34
20
1
Jan 2020
53
17
2
Feb 2020
40
18
4
Mar 2020
56
19
2
Apr 2020
33
22
1
May 2020
70
26
3
Jun 2020
38
18
4
Jul 2020
63
18
2
Aug 2020
27
19
6
Sep 2020
66
22
3
Oct 2020
53
19
4
Nov 2020
27
2
1
Dec 2020
73
2
3
Jan 2021
28
3
4
Feb 2021
52
8
5
Mar 2021
67
8
8
Apr 2021
45
8
6
May 2021
16
2
2
Jun 2021
7
6
4
Jul 2021
3
3
5
Aug 2021
2
2
1
Sep 2021
5
5
6
Oct 2021
45
2
3
Nov 2021
27
2
2
Dec 2021
17
1
1
Jan 2022
25
4
2
Feb 2022
26
0
0
Mar 2022
22
2
2
Apr 2022
22
0
0
May 2022
39
3
1
Jun 2022
56
1
1
Jul 2022
55
4
0
Aug 2022
60
4
3
Sep 2022
46
2
2
Oct 2022
69
9
0
Nov 2022
24
3
0
Dec 2022
60
2
0
Jan 2023
19
3
3
Feb 2023
48
2
1
Mar 2023
13
3
3
Apr 2023
10
0
0
May 2023
12
0
0
Jun 2023
3
1
1
Jul 2023
20
0
0
Aug 2023
13
0
0
Sep 2023
19
1
1
Oct 2023
47
1
1
Nov 2023
44
0
1
Dec 2023
34
4
2
Jan 2024
47
2
1
Feb 2024
28
2
1
Mar 2024
5
3
2
Apr 2024
52
6
6
May 2024
22
0
1
Jun 2024
32
3
0
Jul 2024
37
2
0
Aug 2024
17
1
0
Sep 2024
33
1
0
Total
6397
1091
548
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?